Author

Ghassan Al-Jazayrly

Observed names: G Al-Jazayrly, G.M. Al-Jazayrly, Ghassan Al-Jazayrly,

Observed institutions: University of California Davis Medical Center, University of California, Davis

OpenAlex ID: A5088861982

Phase I Trial of Gemcitabine and Paclitaxel in Advanced Solid Tumors

2003 · Nelson Lim,, Primo N. Lara, et al. · Cancer Investigation · 7

BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

2021 · Wojciech Jurczak, Caroline Dartigeas, et al. · Blood · 2

Abstract PS13-16: Pharmacokinetic evaluation of an oral paclitaxel DHP107 (Liporaxel®) in patients with recurrent or metastatic breast cancer (MBC): Phase II study (OPERA, NCT03326102)

2021 · Hope S Rugo, Timothy J Pluard, et al. · Cancer Research · 2

1850MO TeLuRide-005: Phase II study of EIK1001, a toll-like receptor 7/8 (TLR7/8) co-agonist with pembrolizumab (pembro)+chemotherapy (chemo) as first-line (1L) therapy in stage 4 non-small cell lung cancer (NSCLC)

2025 · D. Costin, R. Jotte, et al. · Annals of Oncology · 1

CLL-129 BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

2022 · Alex Levy, Wojciech Jurczak, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

A phase 2 clinical trial in progress of (Z)-endoxifen plus goserelin as neoadjuvant therapy in premenopausal women with ER+/HER2– breast cancer (EVANGELINE).

2026 · Steven Quay, Vera Jean Suman, et al. · Journal of Clinical Oncology

Poster: CLL-129 BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

2022 · Alex Levy, Wojciech Jurczak, et al. · Clinical Lymphoma Myeloma & Leukemia

ASCO Update: Chronic Lymphocytic Leukemia

2002 · N. Simon Tchekmedyian, FACP. FACP., et al.

ASCO Update: Non-Hodgkin’s Lymphoma

2002 · N. Simon Tchekmedyian, FACP. FACP., et al.

The price of remission.

1997 · G Al-Jazayrly, D H Lau · PubMed

Works count: 10

Citation count: 13

H-index: 2

I10-index: